Sign Up to like & get
recommendations!
1
Published in 2018 at "International Journal of Women's Dermatology"
DOI: 10.1016/j.ijwd.2018.03.004
Abstract: The use of high-dose intravenous immunoglobulin (IVIG) is an accepted therapy for patients with refractory dermatomyositis. Cases of eczematous reactions to IVIG have been reported in the literature, but to our knowledge, none in patients…
read more here.
Keywords:
high dose;
eczematous reaction;
reaction ivig;
ivig ... See more keywords